Results for tag: "Verzenio"

Verzenio is a type of breast cancer drug used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It is a type of CDK4/6 inhibitor, which works by blocking the activity of certain proteins that can cause cancer cells to grow and divide. Verzenio is taken orally and is usually prescribed in combination with an aromatase inhibitor. It is approved for use in the United States, Europe, and other countries. Verzenio is one of several drugs used to treat breast cancer. Other drugs used to treat breast cancer include hormone therapy, chemotherapy, targeted therapy, and immunotherapy. Each type of drug works differently and is used in different stages of the disease. Companies in the Verzenio market include Eli Lilly, Novartis, Pfizer, and AstraZeneca. Show Less Read more